Ann: Shareholder Update, page-17

For 10+ years OBJ was incorrectly valued with a MC of over $20m. It sat around $25m for the past 2-3 years.

Now we have revenue building, are in complete control of our company’s future, have an astute CEO and yet the MC is $12m.

It is clear the market doesn’t understand the space or how to value the company.

With any other ASX listed company, the below would send the SP 10-15% up...

From today’s update:

”Delivery of various medical products as inhalants and in buccal applications with an internationally renowned pharma company.”

”A total of three collaborations with beauty companies focused on RÉDUIT’s enhanced delivery system covering use of both RÉDUIT existing formulations, as well as adaptations of the partner companies’ formulations.”

Yet we drop 8%. Doesn’t make sense. Anyway, behind the scenes the progress is impressive and if it was valued by PE it would be many multiples of the current MC.